By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovoCure Ltd. 

Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


Medical Device

Company News
NovoCure Announces National Reimbursement For Optune In Austria 8/8/2017 11:59:36 AM
NovoCure To Present At The 2017 Wedbush Pacgrow Healthcare Conference 8/2/2017 8:05:20 AM
NovoCure Reports Second Quarter 2017 Financial Results And Provides Company Update 7/27/2017 6:53:54 AM
NovoCure Announces A Phase Ib Clinical Trial To Evaluate The Safety Of Marizomib And Temozolomide In Combination With Optune® As Adjuvant Therapy In Patients With Glioblastoma 7/24/2017 7:04:23 AM
NovoCure’s Optune Now Available At More Than 600 Cancer Treatment Centers In The U.S. 7/12/2017 6:34:54 AM
NovoCure Data On Delivery Of Tumor Treating Fields To Be Presented At The 39th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society 7/11/2017 6:30:25 AM
NovoCure To Report Second Quarter 2017 Financial Results 6/30/2017 6:15:23 AM
NovoCure To Present Three Abstracts On Tumor Treating Fields And Pancreatic Cancer At The European Society For Medical Oncology 19th World Congress On Gastrointestinal Cancer 6/28/2017 10:31:05 AM
NovoCure Release: First Patient Enrolled In RTOG Trial Of Optune Together With Bevacizumab For Patients With Bevacizumab-Refractory Recurrent Glioblastoma 6/8/2017 7:07:18 AM
NovoCure Release: Health Care Service Corporation Issues Positive Coverage Decision For Optune 6/5/2017 7:30:51 AM